Sort
326,823 grants matching “clinical trial”
Case Clinical Trials Unit
$2,436,364Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2023 · AI
From cells to complex syndromes: using networks to understand heterogeneity in TDP-related frontotemporal degeneration and aging
$2,436,318Murray Grossman · University Of Pennsylvania · P01 · FY2020 · AG
HEAL: Induced Pluripotent Stem Cell (iPSC)-Derived Cell Types for Pain, Addiction and Overdose
$2,436,123Ilyas Singec · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
SPORE in Prostate Cancer
$2,436,043Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2018 · CA
SPORE in Prostate Cancer
$2,436,043Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2017 · CA
Development and Validation of Therapy for Mucopolysaccharidosis III
$2,435,870Jill Wood · Phoenix Nest, Inc. · U44 · FY2022 · NS
UC/UIC Comparative Effectiveness Research Institutional Career Development Award
$2,435,723David O Meltzer · University Of Chicago · KM1 · FY2010 · CA
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)
$2,435,695Linmarie Sikich · Univ Of North Carolina Chapel Hill · U01 · FY2013 · HD
Primate Core - Core D
$2,435,589J. Mark Cline · Duke University · U19 · FY2016 · AI
BIOLOGICAL MARKERS OF BREAST CANCER &TAMOXIFEN RESPONSE
$2,435,409University Of Pennsylvania · P01 · FY2002 · CA
Development of the Inspired Therapeutics NeoMate Mechanical Circulatory Support System for Neonates and Infants
$2,435,370Daniel Tamez · Inspired Therapeutics, Llc · R44 · FY2023 · HL
THERAPY OF AML
$2,435,347University Of Texas Md Anderson Can Ctr · P01 · FY2005 · CA
Adenovirus-vectored nasal anthrax vaccine
$2,435,173Vaxin Inc. · UC1 · FY2005 · AI
The Osteoarthritis Prevention Study (TOPS)
$2,435,017Stephen P Messier · Wake Forest University · U01 · FY2024 · AR
THE IMPACTA PERU CLINICAL TRIALS UNIT
$2,434,595Jorge Luis Sanchez · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2013 · AI
The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer
$2,434,565Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA
DAIT CLINICAL SITE MONITORING CENTER
$2,434,475Mary Glessner · Ppd Development Lp · N01 · FY2017 · AI
EO-NAT HIV Rapid Point-of-Care Diagnostic Device for Resource-Limited Settings
$2,434,269Ph.d., Daniel Laser · Wave 80 Biosciences, Inc. · N01 · FY2013 · AI
The effect of noise induced hearing loss on Alzheimer's disease development and progression
$2,434,000Hong-Bo Zhao · Yale University · RF1 · FY2023 · AG
Data Acquisition and Analysis Core
$2,433,782Sara Jane Webb · Yale University · U19 · FY2024 · MH
Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network: Statistics and Data Management Core
$2,433,663Janet Ellen Dancey · Queen'S University At Kingston · U10 · FY2022 · CA
HIV-1 Vaccines Designed to Induce Mucosal Immunity
$2,433,228University Of California Davis · U19 · FY2003 · AI
DSC MANAGEMENT AND SUPPORT FOR HELPING TO END ADDICTION LONG-TERM INITIATIVE (HEAL). 9/1/2021-8/31/2022. N01DA-19-2250. TASK ORDER 75N95021F00005 (TO2
$2,432,878Paul Vanveldhuisen · The Emmes Company, Llc · N01 · FY2021 · DA
Advancing Islet Transplants for Type 1 Diabetes Care
$2,432,755Bernhard Josef Hering · University Of Minnesota · U01 · FY2006 · AI
Paving the Way to Phase 2 Trials of CMS121 for Alzheimer's Disease
$2,432,649William C Raschke · Virogenics, Inc. · R44 · FY2024 · AG